Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the price of this innovative drug and its availability have become key topics for patients and healthcare professionals. While tirzepatide has been cleared by regulatory agencies, its expensive nature presents a significant obstacle to